269 related articles for article (PubMed ID: 11061889)
1. Scoring the short form ICSmaleSF questionnaire. International Continence Society.
Donovan JL; Peters TJ; Abrams P; Brookes ST; de aa Rosette JJ; Schäfer W
J Urol; 2000 Dec; 164(6):1948-55. PubMed ID: 11061889
[TBL] [Abstract][Full Text] [Related]
2. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
[TBL] [Abstract][Full Text] [Related]
4. Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH.
Bertaccini A; Vassallo F; Martino F; Luzzi L; Rocca Rossetti S; Di Silverio F; Comunale L
Eur Urol; 2001; 40 Suppl 1():13-8. PubMed ID: 11598348
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia.
Barry MJ
Urology; 2001 Dec; 58(6 Suppl 1):25-32; discussion 32. PubMed ID: 11750246
[TBL] [Abstract][Full Text] [Related]
6. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire.
Donovan JL; Abrams P; Peters TJ; Kay HE; Reynard J; Chapple C; De La Rosette JJ; Kondo A
Br J Urol; 1996 Apr; 77(4):554-62. PubMed ID: 8777617
[TBL] [Abstract][Full Text] [Related]
7. The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms.
Peters TJ; Donovan JL; Kay HE; Abrams P; de la Rosette JJ; Porru D; Thüroff JW
J Urol; 1997 Mar; 157(3):885-9. PubMed ID: 9072592
[TBL] [Abstract][Full Text] [Related]
8. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-'BPH' study.
Donovan JL; Brookes ST; de la Rosette JJ; Peters TJ; Porru D; Kondo A; Dabhoiwala N; Millard R; Bosch R; Nordling J; Matos Ferreira A; Höfner K; Mostafid H; Walter S; Nissenkorn I; Frimodt Moller C; Mendes Silva M; Chapple C; Abrams P
BJU Int; 1999 Feb; 83(3):243-8. PubMed ID: 10233487
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of the BSP-BPH (Bononian Satisfaction Profile--Benign Prostatic Hyperplasia) a "disease-specific" questionnaire for the evaluation of health related quality of life in patients with benign prostatic hyperplasia.
Bertaccini A; Martinelli A; Ceccarelli R; Palmieri F; Vitullo G; Urbinati M; Marchiori D; Costal F; Martorana G
Arch Ital Urol Androl; 2004 Sep; 76(3):103-9. PubMed ID: 15568297
[TBL] [Abstract][Full Text] [Related]
10. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Arabic linguistic version of the Danish Prostatic Symptom Score for benign prostatic hyperplasia associated with lower urinary tract symptoms.
Hashem A; Laymon M; Taha MT; Elshabrawy M; Ghorab MM; Elshal AM; Sheir KZ
Arab J Urol; 2021; 19(4):464-468. PubMed ID: 34881063
[No Abstract] [Full Text] [Related]
12. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
[TBL] [Abstract][Full Text] [Related]
13. Impact of surgical treatment on nocturia in men with benign prostatic obstruction.
Cai T; Gardener N; Abraham L; Boddi V; Abrams P; Bartoletti R
BJU Int; 2006 Oct; 98(4):799-805. PubMed ID: 16978275
[TBL] [Abstract][Full Text] [Related]
14. Relevance and variability of the severity of incontinence, and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms.
Haltbakk J; Hanestad BR; Hunskaar S
BJU Int; 2005 Jul; 96(1):83-7. PubMed ID: 15963126
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
[TBL] [Abstract][Full Text] [Related]
16. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia.
Hansen BJ; Flyger H; Brasso K; Schou J; Nordling J; Thorup Andersen J; Mortensen S; Meyhoff HH; Walter S; Hald T
Br J Urol; 1995 Oct; 76(4):451-8. PubMed ID: 7551880
[TBL] [Abstract][Full Text] [Related]
17. Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire.
Clayson D; Wild D; Doll H; Keating K; Gondek K
BJU Int; 2005 Aug; 96(3):350-9. PubMed ID: 16042729
[TBL] [Abstract][Full Text] [Related]
18. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
Kaplan SA; Olsson CA; Te AE
J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
[TBL] [Abstract][Full Text] [Related]
19. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.
Ushijima S; Ukimura O; Okihara K; Mizutani Y; Kawauchi A; Miki T
J Urol; 2006 Aug; 176(2):665-71. PubMed ID: 16813918
[TBL] [Abstract][Full Text] [Related]
20. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
